DE
Therapeutic Areas
Tavanta Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Colorectal Program(s) | Colorectal Cancer | Phase 2 |
| Undisclosed Uro-oncology Program(s) | Uro-oncology (e.g., bladder, kidney, prostate cancers) | Phase 2 |
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Colorectal Program(s) | Colorectal Cancer | Phase 2 |
| Undisclosed Uro-oncology Program(s) | Uro-oncology (e.g., bladder, kidney, prostate cancers) | Phase 2 |